GlobeVerge

Canada is now the second country to authorize a Phase I clinical trial for a Bundibugyo virus vaccine candidate after the U.K., according to federal officials in a news release.
Public health developments like this can directly affect healthcare decisions and guidance. Directly involves Canada.